ASH Clinical News April 2016 | Page 7

INTRODUCING IDELVION NOW APPROVED The first and only rFIX therapy that delivers high-level protection with up to 14-day dosing* *In well-controlled patients 12 years and older, defined as 1 month without spontaneous bleeding on a weekly dose of ≤40 IU/kg. Important Safety Info